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Abstract
Objective. Compare the influence of ethnicity in the preva-
lence of osteopenia and osteoporosis in various Mexican 
populations using two normal dual X-ray absorptiometry 
(DXA) reference databases: manufacturer’s incorporating US 
Hispanic population and a normal mestizo Mexican popula-
tion. Material and Methods. MMP included 9 946 subjects 
participating in an ongoing long-term cohort study focusing 
on lifestyle and chronic diseases, of which 6 487 MMP males 
and females aged 7 to 80 years were the normal subjects 
used to determine bone density T- and Z-scores, following 
WHO criteria, and peak bone mass values. Abnormal bone 
mass density values estimated by the manufacturer’s and peak 
bone mass reference values were compared. Results and 
Conclusions. Our results show that by using the manu-
facturer’s T-score values in the mestizo Mexican population 
we are underestimating the number of abnormal bone mass 
BMD populations.
Key words: bone densitometry, normal reference values, 
ethnicity, Mexico
Tamayo J, Díaz R, Lazcano-Ponce E, Muñoz M,
Huitrón G, Halley E, Díaz-Montiel JC, Mudgal J,
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Resumen
Objetivo. Comparar la influencia de la etnicidad en la pre-
valencia de osteopenia y osteoporosis en varias poblaciones 
mexicanas utilizando dos bases de referencia normal de 
densitometría de rayos X (DXA): referencia del fabricante 
que incorpora hispanos en Estados Unidos y datos de una 
población mestiza mexicana. Material y métodos. Un total 
de 9 946 sujetos de población mestiza mexicana participantes 
en una cohorte de largo plazo dirigida al estudio de estilos 
de vida y ocurrencia de enfermedades crónicas; de los cuales 
6 487 sujetos sanos de ambos sexos, con edad entre los 7 
y los 80 años, fueron utilizados para determinar los valores 
T, Z, de acuerdo a los criterios de la OMS, así como a los 
valores de masa ósea pico. Se compararon los casos de 
densidad mineral ósea anormal de acuerdo a los valores de 
referencia del fabricante y los valores de masa ósea pico de 
la población mestiza. Resultados y conclusión. Las bases 
de referencia del fabricante subestima significativamente el 
número de casos con densidad mineral ósea anormal en la 
población mestiza mexicana.
Palabras clave: densitometría ósea, valores normales referen-
cia, etnicidad; México
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Osteoporosis and its most common complication, fra-gility fractures, are well recognized internationally 
as public health problems.1-6 Mexico is no exception, as 
femoral fractures account for nearly 40 000 hip replace-
ment surgeries performed in the nation each year7-13 
with an estimated direct cost of 800 000 US dollars. In 
1994, the World Health Organization (WHO) developed 
criteria to classify bone mineral density (BMD) values 
as an estimation of lifelong relative fracture risk14  and 
to classify people as osteopenic or osteoporotic based 
on the low energy dual x-ray absorptiometry (DXA) 
T-score values of healthy young adults (20 to 40 years 
old). BMD is influenced by genetic and lifestyle factors 
which may significantly vary between ethnic groups. 
BMD reference values for the US Hispanic population 
are available from the National Health and Nutrition 
Examination Survey (NAHNES) and can be found in 
clinical equipment software. However, there are no 
such reference values available for the healthy Mexican 
population, which is ethnically distinct from the US 
Hispanic population. 
 Over the last 15 years, DXA has been widely used 
to determine bone mineral density (BMD) at different 
anatomical sites. This technology has been used for early 
detection of individuals at high risk of osteoporotic frac-
tures. According to these WHO criteria, T-scores should 
be developed based on mean BMD values +/- standard 
deviation (SD) among a reference population of healthy 
young adults (20 to 40 years old). These criteria have 
been adopted as the optimal bone strength reference 
values to qualify as osteopenic or osteoporotic, based 
on the BMD evaluation. A T-score value above 1.0 SD 
is considered normal, between -1.0 and -2.5 SD as os-
teopenia, and below -2.5 as osteoporosis.14-16 A Z-score 
was also developed as a comparison for BMD deter-
minations against age- and gender-matched healthy 
individuals. The lifelong relative fracture risk for the 
osteopenic range increased to 1.6 and it was over 2.0 
for the osteoporotic range. The prediction is stronger 
if data is analyzed for the specific region of interest, 
namely, if one measures femoral neck results to predict 
the relative risk of having a femoral neck fracture; in 
such an example the relative risk increases to over 2 for 
an osteopenic BMD value and to over 6 for osteoporotic 
values.14  
 In order to minimize the differences between refer-
ence populations, researchers sought to generate BMD 
reference values for different ethnic groups in the United 
States based on National Health and Nutrition Examina-
tion Survey (NHANES) data.17-19 T-scores for Hologic 
and Lunar instruments have thus been developed for 
specific anatomical regions among 20 to 40 year-old 
healthy adult men and women and for different ethnici-
ties. During the last 10 years, these estimates have been 
used as reference values for operational and diagnostic 
purposes at the clinical level.
 In recent years, the use of BMD T-score values for 
different ethnic groups and countries has been ques-
tioned in light of increasing evidence that the true maxi-
mal bone strength at skeletal maturity is the peak bone 
mass (PBM), representing the optimal bone mass of an 
individual.20 It is now believed that a T-score computed 
using this optimal bone strength value (PBM) may be a 
better reference than the mean of a healthy young adult 
population because bone mass is still increasing21-22 in 
individuals between 20 and 30 years of age. Therefore, 
including sub-optimal BMD estimates in the calculation 
of T-scores may lead to a significant underestimation of 
osteopenic and/or osteoporotic cases.
 BMD is the strongest predictive factor of frac-
tures that can be assessed with high reproducibility 
and specificity.22-26 To use this predictor in Mexico, it 
is thus crucial to have reference PBM values for the 
Mexican population in order to compute a T-score that 
truly reflects optimal bone strength at skeletal maturity. 
Adopting national standards based on BMD reference 
values and T-score estimates for our population may 
improve the assessment of osteoporosis in Mexico. 
Since anti-fracture interventions provide over 50 percent 
protection against osteoporotic fractures after the first 
year of treatment, improved ability to assess fracture 
risk would improve both public health decision making 
and clinical outcomes.3 
 The aim of the study is to provide BMD reference 
values based on a healthy, urban Mexican population 
aged 7 to 80 years and stratified by sex, enabling us 
to estimate the PBM reference values for the Mexican 
population. These values are necessary for computing 
a T-score that truly reflects optimal bone strength at 
skeletal maturity in this population. Using these BMD 
reference values, we are able to calculate optimal BMD 
T- and Z-scores, both according to WHO criteria and 
PBM values. Adopting these reference values as a na-
tional standard can improve public health practices and 
clinical assessment of osteoporosis in Mexico. 
Material and Methods
Study Population: The present analysis was performed 
with healthy employees and their healthy relatives 
from three different health and academic institutions: 
Instituto Mexicano del Seguro Social (IMSS) and the Ins-
tituto Nacional de Salud Pública (INSP) in Cuernavaca, 
Morelos, Mexico, and employees from the Universidad 
Autónoma del Estado de México (UAEM) in Toluca, 
State of Mexico. Subjects recruited for the study were 
Artículo originAl
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participating in the first stage of an ongoing, long-term 
cohort study focusing on lifestyle and health, approved 
by the respective ethical committees of each participat-
ing institution; informed consent was obtained in all 
cases. Out of a total population of 13 275 study candi-
dates identified between March 2004 and April 2006, 
9 467 employees were invited to participate in the cohort 
study and a total of 8 307 adults were formally enrolled. 
Those participants who were parents of children 7 to 
18 years of age (about 20% of the employees) were also 
asked to invite their children to be part of the study. Of 
those willing to participate, 1 639 youths were formally 
invited and enrolled in the study. Thus, a total of 9 946 
subjects between 7 and 92 years of age were formally 
recruited. BMD determinations in this study popula-
tion constitute part of a more extensive epidemiologic 
evaluation designed to prospectively evaluate different 
hypotheses about the relationships between lifestyle and 
chronic disease occurrence in Mexico. 
 For the present analysis, we excluded subjects older 
than 80 years of age as well as participants with chronic 
diseases that may affect bone metabolism and/or alter 
the BMD values, such as: diabetes (n=631), cancer (n=96), 
obesity (BMI >35, n=262), arthritis (n=286), kidney stones 
(n=182), renal dysfunction (creatinine >2 mg/dL for men, 
>1.8 mg/dL for females, n=283) previously diagnosed 
osteopenia/osteoporosis or fractures after the age of 45 
(n=64), use of medications that may alter bone metabolism 
(n=69), and weight change in previous year (>10 kg, n=89). 
We also excluded pregnant women and those women who 
were unable to undergo BMD measurements. The final 
healthy reference population for the present analysis is 
6 478. This large sample allowed us to estimate PBM as 
well as T- and Z-scores. The general characteristics of this 
population are depicted in table I.
BMD assessment  
Bone density measurements were performed at the non-
dominant proximal femur, the lumbar spine (L1-L4), and 
whole body using a DXA Lunar DPX NT instrument. 
The user manual instructions and International Society 
of Clinical Densitometry (ISCD) procedures were strictly 
followed.16,27 Standardized densitometry technicians 
performed all BMD measurements. Standard calibra-
tion of instruments was performed daily using the 
phantom provided by the manufacturer; technicians 
ensured that the daily variation coefficient (VC) was 
within normal operational standards and in vivo VC 
was lower than 1.5%. Results obtained by DXA are 
expressed as grams of hydroxyapatite per square cen-
timeter (WHO Technical Report Series: Prevention and 
Management of Osteoporosis. http://whqlibdoc.who.
int/trs/WHO_TRS_921.pdf). 
T- and Z-scores estimates procedures 
In order to compute T-scores by specific site (total 
body, femur and lumbar spine), we first estimated the 
reference value for PBM in our population following a 
previously reported procedure.28 Briefly, we calculated 
the difference in g/cm2 between the BMD of a subject 
and the PBM for the corresponding sex. The difference 
between these values is expressed as standard devia-
tion (SD), or in other words, the difference between the 
studied subject and the PBM is standardized. The T-
score obtained with this method represents the differ-
ence expressed by the number of standard deviations 
between the Young Normal (YN) value of the population 
of the same sex and the BMD of the subject studied. This 
sequence is summarized by the following formula: 













Mean SD Mean SD Mean SD Mean SD Mean SD Mean SD
Age 13.03 3.10 36.50 8.84 60.99 8.24 13.44 3.12 36.28 8.78 60.87 8.21
Height 156.06 17.01 169.27 6.72 166.53 6.60 151.88 11.82 156.90 28.21 153.05 5.85
BMI 20.56 4.58 26.37 3.43 26.50 3.15 21.05 4.21 25.44 3.75 26.93 3.51
Abdominal cir-
cunference 76.07 13.28 91.11 9.03 94.47 8.57 77.00 11.71 85.64 10.00 94.68 10.99
% fat 24.18 10.97 28.41 6.71 29.87 6.32 35.23 9.01 41.11 6.48 43.94 5.76
Table 1
PoPulation characteristics for a cohort study on lifestyle and health. Mexico
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(BMD - YN)
SD
Similarly the Z-value or Z-score represents the com-
parison between the subject’s BMD and the mean BMD 
value of the healthy adult population of the same age 
and sex, referred to as Adult Mean Normal (AMN). It 
is also used as a measure of the standard deviation of 




We evaluated 6 478 healthy men and women from 7 to 
80 years of age who did not have conditions affecting 
bone health, out of a total of 8 307 adults and 1 603 of 
their children formally enrolled in the first stage of an 
ongoing, long-term cohort study focusing on lifestyle 
and health. This recruitment strategy allowed us to 
have a cohort with healthy bones resembling the real 
ethnical mixture of a socioeconomic urban middle class 
population reflecting a wide sector of the Mexican 
population. 
 As shown in figure 1, BMD increases from infancy 
on and reaches PBM sometime between the late twen-
ties and the mid thirties. Once PBM is reached, there is a 
progressive decrease in BMD with advancing age; these 
values curve as the population grows older and vary by 
sex and by skeletal region. Male BMD values are always 
greater than female BMD values. As shown in Figure 1, 
males reach the PBM subtotal of the skeleton and whole 
body BMD values (excluding the skull) between ages 22 
and 25, while females do so at 27. Males reach PBM of 
the total femur measurement at age 23, while females 
reach it at age 27. Males and females both reach PBM 
of the lumbar spine at age 32. 
 Z-score values are depicted in figure 2. The curves 
for female BMD values are dramatically different than 
those for male values; male values are greater than fe-
male values starting in early childhood and continuing 
throughout life. It should also be noted that the values 
decrease less dramatically for males in later adulthood 
compared to females. Z-scores reflect a comparison 
of the individual patient compared to age- and sex-
matched controls and can be used to evaluate follow-up 
studies in other clinical applications. 
 According to WHO recommendations, computa-










      7      10      13     16      19      22     25     28      31     34      37
Age (years)

















      7      10      13     16      19      22     25     28      31     34      37
Age (years)








figure 1. Bone Mineral density distriBution for three 
anatoMical regions in Mexican Males and feMales froM 
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figure 2. reference ParaMeters for Bone Mineral den-
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Subtotal bone mineral density Z scores in females
point for defining the presence of osteopenia and/or 
osteoporosis in each specific population. Therefore, 
both the method for computing T-scores and the refer-
ence population used for these computations must be 
optimized to generate accurate frequency estimates of 
these health problems. Currently, using instruments on 
one population that have been calibrated for another can 
thus impede accurate measurement. The DEXA instru-
ments used in Mexico compute T-scores according to 
the BMD mean derived from a reference population of 
healthy US Hispanics between ages 20 and 40. In table II, 
we document the differences in the number of osteopenic 
and osteoporosis cases that occur when US Hispanics 
versus Mexicans are used as reference populations. 
 Our results indicate that, by using the normal 
reference T-scores obtained from the BMD values for 
the normal female population aged 20 to 40 in our 
cohort to classify the individual BMD values obtained 
from two large patient populations (the abnormal 
population in our cohort and the BMD data obtained 
and kindly provided to us by Deleze, Cons et al. [pre-
viously used for another publication29]) that included 
4 460 women aged 50 and older who were classified as 
normal, osteopenic or osteoporotic by 10 densitometry 
centers located across the country, a higher prevalence 
of osteopenia and osteoporosis is observed compared to 
the prevalence obtained using the reference population 
of healthy US Hispanics integrated in the densitometer 
by the manufacturer (see figure 3 and tables A.1-A.4 at 
the appendix). If we restrict the reference population to 
only those between the ages of 30 to 40 years, there is 
not a greater underestimation of cases of osteopenia and 
osteoporosis found using the manufacturer’s database 
(figure 3). If the T-score is computed using the PBM 
value instead of mean BMD, which we consider to be 
a more realistic way to define the optimal bone quality 
reached at skeletal maturation,21 the degree of discrep-
ancies between the manufacturer’s and our estimates 
of osteopenia and osteoporosis are substantially similar 
using the T-scores obtained from either of our Mexican 
populations (women ages 20 to 40 or ages 30 to 40 years 
old) (figure 3).
 It is clear that by using the manufacturer’s T-score 
values to classify our abnormal Mexican population, we 
are underestimating the number of abnormal BMD cases. 
Using either our own T-scores calculated for populations 
aged 20 to 40 or 30 to 40, or our PBM, we found that 
24.22% of the cohort population is osteopenic, whereas 
using the manufacturer’s T-score for this value is only 
16.52%. The results are similar for osteporotic classifica-
tion: using PBM we detect a prevalence of 9.73% versus 
6.79% when using the manufacturer’s values. Analyzing 
the data obtained from the Deleze, Cons cohort with the 
same criteria, it also became clear that there is a signifi-
cant underestimation, restricted only to the femoral neck 
region (tables A.1-A.4 at the appendix).
 Tables III.1-III.2 provide a comprehensive reference 
for the PBM-derived T-score values for a male and fe-
male Mexican population. These tables include reference 
values for both sexes for the 1) total skeleton (exclud-
ing the head from whole body scans), 2) the complete 
proximal femur, and 3) the lumbar region (L1-L4). Tables 
IV.1-IV.18 describe the Z-score for the same population, 
depicting each age and the corresponding BMD. These 
S61salud pública de méxico / vol. 51, suplemento 1 de 2009
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tables can be used manually to find the T-score and Z-
score for the urban Mexican population.
Discussion
WHO guidelines are helpful for clinically adapting 
previous definitions of osteoporosis; practically speak-
ing, these guidelines allow for greater accuracy when 
describing the extent and characteristics of osteoporosis. 
However, the expert panel that created these guidelines 
recognized that they would likely change as new knowl-
edge was gathered.30 Today, it has become quite evident 
that fracture risk is also affected by factors other than 
BMD; not all individuals with low BMD will fracture, 
while some with normal BMD will.31 Also, WHO criteria 
define low BMD without regard to an individual’s age, 
missing a key element of fracture risk. For example, 
though a 40 year-old and 65 year-old woman may have 
the same BMD levels, the older woman’s probability 
of suffering a fracture is increased by the concurrent 
presence of other risk factors.33-35 In addition to exclud-
ing age from risk assessment, WHO criteria do not use 
PBM values as the optimal bone quality, using the less 
accurate mean BMD distribution for young adults (20 
to 40 years old). The rationale behind the use of this age 
range is not clearly identified, nor is it clear how to form 
a reference group for populations that include different 
racial or ethnic groups.22-26, 32 
Table II
concordance of osteoPenia and osteoPorosis Prevalence according
to different t score coMPutations derived froM different reference PoPulations












Normal (%) 68.57 8.13 0.00 76.70
Osteopenia(%) 0.04 14.29 2.18 16.52
Osteoporosis(%) 0.00 0.45 6.34 6.79
Total (%) 68.61 22.87 8.52 100.00












Normal (%) 66.92 9.77 0.00 76.70
Osteopenia(%) 0.03 13.67 2.82 16.52
Osteoporosis(%) 0.00 0.48 6.31 6.79
Total (%) 66.95 23.92 9.13 100.00












Normal (%) 66.02 10.68 0.00 76.70
Osteopenia(%) 0.03 13.37 3.12 16.52
Osteoporosis(%) 0.00 0.17 6.61 6.79
Total (%) 66.05 24.22 9.73 100.00
*T score from the total body BMD mean derived from a 20 – 40 year old, US Hispanic population
Artículo originAl
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 To address a few of these emerging issues, we used 
the worker’s cohort study data with the T-score refer-
ence values that reflect the population’s unique charac-
teristics to study bone density data from a large number 
of subjects of both sexes, age 7 to 80. This was done in 
order to determine whether there were differences in 
the number of people classified as having a higher than 
normal lifelong relative risk of having a fracture, in 
order to build a normal mestizo reference database that 
allowed us to define the age at which PBM is established 
at different skeletal sites. To the best of our knowledge, 
our study is the largest reported in Latin America, with 
a data set comprised of healthy, urban mestizos from 
early childhood to old age, which may represent more 
than 70% of the Mexican population. PBM and T-scores 
derived for this population differ significantly from 
values derived from commercial manufacturer’s US 
Hispanic database, with our data reflecting significantly 
higher values and a curve indicating that age-dependent 
BMD loss is also very different. The T-score derived 
from our PBM values had only an 86% concordance 
with the manufacturers’ Hispanic values that classify 
the normal population using PBM reference values, and 
up to 89% for T-score values for the population aged 20 
to 40. Using our reference values, the number of people 
in the range of osteopenia and osteoporosis increased 
by 31 and 32 percent, respectively. As expected, this 
lack of concordance between the Mexican database 
and the manufacturers’ Hispanic database increases as 
age increases. Revising estimates of fracture risk based 
on our numbers will have a major clinical impact since 
fracture prevention interventions will increase.29 
 Since our Mexican database of reference values are 
not currently included in the software of commercial 
densitometers used in Mexico, interested users can 
classify their specific BMD values reported by these 
instruments according to the reference values presented 
in the BMD tables of this report (tables III.1-III.2, IV1-
IV.18). Having normative BMD reference values for 
the urban Mexican population will be very relevant 
for our densitometry community. This more accurate 
normative reference data may give us the opportunity 
to improve the decision making process used in the 
prevention and care of bone density-related public 
health problems, though we must ensure that it does 
not simply amount to an increased burden on an al-
ready strained healthcare system. These considerations 
should be taken into account by policy makers in or-
der to improve the Mexican healthcare infrastructure 
as well as to seek new ways to address the growing 
populations’ healthcare needs.    
figure 3. concordance of osteoPenia and osteoPorosis 
Prevalence according to different t-score coMPuta-










                 Normal                    Osteopenia                Osteoporosis
 
     Classified according to manufacturer
     Classified according to mean BMD for a Mexican population










                 Normal                    Osteopenia                Osteoporosis
 
     Classified according to manufacturer
     Classified according to peak bone mass estimate
     for the Mexican population
 For Mexico, as well as for many other develop-
ing countries, the importance of having BMD T-score 
reference values that reflect the population’s unique 
characteristics has become a critical issue.33,34 Several 
studies have shown that the reference data provided 
by manufacturers for a US Hispanic population may 
lead to dangerous underestimations of the popula-
tion at risk.18,34-38 The reference databases provided by 
manufacturers do not reflect the complex heritage of the 
Mexican population, also called mestizo, which reflects 
both indigenous Mexican and Spanish ancestry. 
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Table III.1
Bone Mineral density t score  for Male PoPulation
T BONE MINERAL DENSITY (g/cm2)
SCORE
Subtotal body Lumbar t=region Hip Head Arm Proximal femur Trunk Ribs Pelvis
-5.0 0.762 0.490 0.480 0.913 0.402 0.785 0.567 0.424 0.601
-4.5 0.811 0.559 0.551 1.042 0.461 0.845 0.614 0.461 0.668
-4.0 0.861 0.629 0.621 1.171 0.520 0.906 0.662 0.498 0.735
-3.5 0.910 0.699 0.692 1.299 0.579 0.967 0.709 0.535 0.802
-3.0 0.960 0.768 0.762 1.428 0.638 1.028 0.757 0.573 0.870
-2.5 1.009 0.838 0.832 1.557 0.697 1.088 0.804 0.610 0.937
-2.0 1.059 0.907 0.903 1.686 0.756 1.149 0.852 0.647 1.004
-1.5 1.108 0.977 0.973 1.815 0.815 1.210 0.899 0.684 1.071
-1.0 1.158 1.047 1.044 1.944 0.874 1.270 0.946 0.722 1.138
-0.5 1.208 1.116 1.114 2.073 0.934 1.331 0.994 0.759 1.206
0.0 1.257 1.186 1.185 2.202 0.993 1.392 1.041 0.796 1.273
0.5 1.307 1.255 1.255 2.331 1.052 1.452 1.089 0.833 1.340
1.0 1.356 1.325 1.326 2.460 1.111 1.513 1.136 0.871 1.407
1.5 1.406 1.395 1.396 2.589 1.170 1.574 1.184 0.908 1.475
2.0 1.455 1.464 1.466 2.718 1.229 1.634 1.231 0.945 1.542
2.5 1.505 1.534 1.537 2.847 1.288 1.695 1.279 0.982 1.609
3.0 1.554 1.603 1.607 2.976 1.347 1.756 1.326 1.020 1.676
3.5 1.604 1.673 1.678 3.105 1.407 1.816 1.374 1.057 1.743
4.0 1.653 1.743 1.748 3.234 1.466 1.877 1.421 1.094 1.811
4.5 1.703 1.812 1.819 3.362 1.525 1.938 1.469 1.131 1.878
5.0 1.752 1.882 1.889 3.491 1.584 1.999 1.516 1.168 1.945
Table III.2
Bone Mineral density t score  for feMale PoPulation
T Bone mineral density (g/cm2)
SCORE
Subtotal body Lumbar region Hip Head Arm Proximal femur Trunk Ribs Pelvis
-5.0 0.783 0.509 0.471 1.088 0.415 0.757 0.586 0.440 0.628
-4.5 0.823 0.576 0.531 1.225 0.460 0.800 0.625 0.470 0.681
-4.0 0.863 0.644 0.591 1.362 0.504 0.844 0.665 0.501 0.735
-3.5 0.902 0.711 0.651 1.499 0.548 0.887 0.705 0.531 0.788
-3.0 0.942 0.778 0.711 1.636 0.592 0.931 0.745 0.562 0.841
-2.5 0.982 0.845 0.770 1.773 0.636 0.974 0.784 0.593 0.895
-2.0 1.021 0.913 0.830 1.910 0.681 1.018 0.824 0.623 0.948
-1.5 1.061 0.980 0.890 2.047 0.725 1.061 0.864 0.654 1.002
-1.0 1.100 1.047 0.950 2.185 0.769 1.105 0.904 0.685 1.055
-0.5 1.140 1.115 1.010 2.322 0.813 1.148 0.943 0.715 1.108
0.0 1.180 1.182 1.070 2.459 0.857 1.192 0.983 0.746 1.162
0.5 1.219 1.249 1.130 2.596 0.901 1.235 1.023 0.777 1.215
1.0 1.259 1.317 1.189 2.733 0.946 1.279 1.063 0.807 1.268
1.5 1.299 1.384 1.249 2.870 0.990 1.323 1.102 0.838 1.322
2.0 1.338 1.451 1.309 3.007 1.034 1.366 1.142 0.869 1.375
2.5 1.378 1.519 1.369 3.144 1.078 1.410 1.182 0.899 1.429
3.0 1.417 1.586 1.429 3.282 1.122 1.453 1.222 0.930 1.482
3.5 1.457 1.653 1.489 3.419 1.167 1.497 1.261 0.961 1.535
4.0 1.497 1.720 1.548 3.556 1.211 1.540 1.301 0.991 1.589
4.5 1.536 1.788 1.608 3.693 1.255 1.584 1.341 1.022 1.642
5.0 1.576 1.855 1.668 3.830 1.299 1.627 1.380 1.052 1.695
Artículo originAl
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Table IV.1





-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.524 0.673 0.772 0.871 1.019 45 0.979 1.127 1.227 1.326 1.474
8 0.581 0.729 0.828 0.927 1.076 46 0.977 1.126 1.225 1.324 1.473
9 0.633 0.782 0.881 0.980 1.129 47 0.976 1.125 1.224 1.323 1.471
10 0.683 0.831 0.930 1.030 1.178 48 0.975 1.123 1.222 1.321 1.470
11 0.729 0.877 0.976 1.075 1.224 49 0.973 1.122 1.221 1.320 1.469
12 0.771 0.919 1.019 1.118 1.266 50 0.972 1.121 1.220 1.319 1.467
13 0.810 0.958 1.057 1.156 1.305 51 0.971 1.119 1.218 1.317 1.466
14 0.845 0.993 1.092 1.191 1.340 52 0.969 1.118 1.217 1.316 1.465
15 0.876 1.025 1.124 1.223 1.372 53 0.968 1.116 1.215 1.315 1.463
16 0.904 1.053 1.152 1.251 1.400 54 0.966 1.115 1.214 1.313 1.462
17 0.929 1.077 1.176 1.275 1.424 55 0.965 1.114 1.213 1.312 1.460
18 0.950 1.098 1.197 1.296 1.445 56 0.964 1.112 1.211 1.310 1.459
19 0.967 1.116 1.215 1.314 1.462 57 0.962 1.111 1.210 1.309 1.458
20 0.981 1.129 1.228 1.328 1.476 58 0.961 1.109 1.208 1.308 1.456
21 0.991 1.140 1.239 1.338 1.487 59 0.959 1.108 1.207 1.306 1.455
22 0.999 1.148 1.247 1.346 1.495 60 0.958 1.107 1.206 1.305 1.453
23 1.005 1.153 1.252 1.351 1.500 61 0.956 1.105 1.204 1.303 1.452
24 1.008 1.156 1.255 1.355 1.503 62 0.955 1.104 1.203 1.302 1.450
25 1.009 1.158 1.257 1.356 1.505 63 0.953 1.102 1.201 1.300 1.449
26 1.009 1.158 1.257 1.356 1.505 64 0.952 1.100 1.199 1.299 1.447
27 1.008 1.157 1.256 1.355 1.504 65 0.950 1.099 1.198 1.297 1.445
28 1.007 1.155 1.254 1.354 1.502 66 0.948 1.097 1.196 1.295 1.444
29 1.005 1.153 1.253 1.352 1.500 67 0.946 1.095 1.194 1.293 1.442
30 1.003 1.152 1.251 1.350 1.498 68 0.944 1.093 1.192 1.291 1.439
31 1.001 1.150 1.249 1.348 1.496 69 0.941 1.090 1.189 1.288 1.437
32 0.999 1.148 1.247 1.346 1.495 70 0.938 1.087 1.186 1.285 1.433
33 0.997 1.146 1.245 1.344 1.493 71 0.934 1.083 1.182 1.281 1.430
34 0.996 1.144 1.243 1.342 1.491 72 0.930 1.078 1.177 1.276 1.425
35 0.994 1.143 1.242 1.341 1.489 73 0.924 1.073 1.172 1.271 1.419
36 0.992 1.141 1.240 1.339 1.488 74 0.918 1.066 1.165 1.264 1.413
37 0.991 1.139 1.238 1.338 1.486 75 0.910 1.059 1.158 1.257 1.406
38 0.989 1.138 1.237 1.336 1.485 76 0.902 1.050 1.149 1.249 1.397
39 0.988 1.136 1.235 1.334 1.483 77 0.892 1.041 1.140 1.239 1.387
40 0.986 1.135 1.234 1.333 1.481 78 0.881 1.030 1.129 1.228 1.376
41 0.985 1.133 1.232 1.331 1.480 79 0.869 1.017 1.116 1.215 1.364
42 0.983 1.132 1.231 1.330 1.478 80 0.855 1.003 1.102 1.201 1.350
43 0.982 1.130 1.229 1.328 1.477
44 0.980 1.129 1.228 1.327 1.476
S65salud pública de méxico / vol. 51, suplemento 1 de 2009
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.199 0.421 0.561 0.700 0.909 45 0.808 1.031 1.170 1.309 1.518
8 0.267 0.489 0.629 0.768 0.977 46 0.807 1.029 1.169 1.308 1.517
9 0.331 0.553 0.693 0.832 1.041 47 0.805 1.028 1.167 1.306 1.515
10 0.391 0.613 0.753 0.892 1.101 48 0.803 1.026 1.165 1.305 1.513
11 0.447 0.669 0.808 0.948 1.156 49 0.802 1.025 1.164 1.303 1.512
12 0.498 0.721 0.860 0.999 1.208 50 0.800 1.023 1.162 1.302 1.510
13 0.546 0.769 0.908 1.047 1.256 51 0.799 1.022 1.161 1.300 1.509
14 0.590 0.813 0.952 1.091 1.300 52 0.798 1.020 1.160 1.299 1.508
15 0.630 0.852 0.991 1.131 1.339 53 0.796 1.019 1.158 1.298 1.506
16 0.665 0.888 1.027 1.166 1.375 54 0.795 1.018 1.157 1.296 1.505
17 0.697 0.919 1.059 1.198 1.407 55 0.794 1.017 1.156 1.295 1.504
18 0.724 0.947 1.086 1.225 1.434 56 0.793 1.016 1.155 1.294 1.503
19 0.748 0.970 1.110 1.249 1.458 57 0.792 1.015 1.154 1.294 1.502
20 0.767 0.990 1.129 1.268 1.477 58 0.792 1.015 1.154 1.293 1.502
21 0.783 1.006 1.145 1.284 1.493 59 0.791 1.014 1.153 1.292 1.501
22 0.796 1.018 1.158 1.297 1.506 60 0.791 1.014 1.153 1.292 1.501
23 0.805 1.028 1.167 1.306 1.515 61 0.791 1.014 1.153 1.292 1.501
24 0.812 1.035 1.174 1.314 1.522 62 0.791 1.014 1.153 1.292 1.501
25 0.817 1.040 1.179 1.319 1.527 63 0.791 1.014 1.153 1.292 1.501
26 0.821 1.043 1.183 1.322 1.531 64 0.792 1.014 1.154 1.293 1.502
27 0.823 1.045 1.185 1.324 1.533 65 0.792 1.015 1.154 1.293 1.502
28 0.824 1.046 1.185 1.325 1.533 66 0.793 1.016 1.155 1.294 1.503
29 0.824 1.047 1.186 1.325 1.534 67 0.793 1.016 1.155 1.294 1.503
30 0.824 1.047 1.186 1.325 1.534 68 0.793 1.016 1.155 1.294 1.503
31 0.824 1.046 1.186 1.325 1.534 69 0.792 1.015 1.154 1.294 1.502
32 0.823 1.046 1.185 1.325 1.533 70 0.790 1.013 1.152 1.292 1.500
33 0.823 1.046 1.185 1.324 1.533 71 0.787 1.010 1.149 1.288 1.497
34 0.822 1.045 1.184 1.323 1.532 72 0.783 1.005 1.145 1.284 1.493
35 0.821 1.044 1.183 1.323 1.531 73 0.776 0.999 1.138 1.277 1.486
36 0.821 1.043 1.182 1.322 1.530 74 0.768 0.991 1.130 1.269 1.478
37 0.819 1.042 1.181 1.321 1.529 75 0.757 0.980 1.119 1.258 1.467
38 0.818 1.041 1.180 1.319 1.528 76 0.744 0.967 1.106 1.245 1.454
39 0.817 1.040 1.179 1.318 1.527 77 0.728 0.951 1.090 1.229 1.438
40 0.816 1.038 1.178 1.317 1.526 78 0.709 0.932 1.071 1.210 1.419
41 0.814 1.037 1.176 1.315 1.524 79 0.687 0.909 1.049 1.188 1.397
42 0.813 1.036 1.175 1.314 1.523 80 0.661 0.884 1.023 1.162 1.371
43 0.811 1.034 1.173 1.312 1.521
44 0.810 1.032 1.172 1.311 1.520
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.374 0.585 0.726 0.867 1.078 45 0.733 0.944 1.085 1.226 1.437
8 0.434 0.645 0.786 0.927 1.138 46 0.731 0.943 1.084 1.225 1.436
9 0.490 0.701 0.842 0.983 1.195 47 0.730 0.941 1.082 1.223 1.435
10 0.542 0.753 0.894 1.035 1.246 48 0.729 0.940 1.081 1.222 1.433
11 0.589 0.801 0.942 1.083 1.294 49 0.728 0.939 1.080 1.221 1.432
12 0.633 0.844 0.985 1.126 1.337 50 0.726 0.938 1.079 1.219 1.431
13 0.672 0.883 1.024 1.165 1.376 51 0.725 0.937 1.077 1.218 1.430
14 0.706 0.918 1.059 1.199 1.411 52 0.724 0.935 1.076 1.217 1.428
15 0.737 0.948 1.089 1.230 1.441 53 0.723 0.934 1.075 1.216 1.427
16 0.763 0.974 1.115 1.256 1.467 54 0.721 0.933 1.074 1.215 1.426
17 0.785 0.996 1.137 1.278 1.489 55 0.720 0.931 1.072 1.213 1.425
18 0.802 1.014 1.155 1.296 1.507 56 0.719 0.930 1.071 1.212 1.423
19 0.816 1.027 1.168 1.309 1.520 57 0.717 0.928 1.069 1.210 1.421
20 0.825 1.036 1.177 1.318 1.529 58 0.715 0.927 1.067 1.208 1.420
21 0.830 1.042 1.183 1.323 1.535 59 0.713 0.925 1.065 1.206 1.418
22 0.832 1.044 1.185 1.326 1.537 60 0.711 0.922 1.063 1.204 1.415
23 0.832 1.043 1.184 1.325 1.536 61 0.708 0.920 1.061 1.202 1.413
24 0.829 1.040 1.181 1.322 1.533 62 0.706 0.917 1.058 1.199 1.410
25 0.824 1.035 1.176 1.317 1.528 63 0.703 0.914 1.055 1.196 1.407
26 0.817 1.029 1.170 1.310 1.522 64 0.699 0.911 1.051 1.192 1.404
27 0.810 1.021 1.162 1.303 1.515 65 0.695 0.907 1.048 1.189 1.400
28 0.803 1.014 1.155 1.296 1.507 66 0.691 0.903 1.044 1.184 1.396
29 0.795 1.006 1.147 1.288 1.499 67 0.687 0.898 1.039 1.180 1.391
30 0.788 0.999 1.140 1.281 1.492 68 0.681 0.893 1.034 1.175 1.386
31 0.781 0.993 1.134 1.275 1.486 69 0.676 0.887 1.028 1.169 1.380
32 0.776 0.987 1.128 1.269 1.480 70 0.669 0.880 1.021 1.162 1.374
33 0.770 0.981 1.122 1.263 1.475 71 0.662 0.873 1.014 1.155 1.366
34 0.765 0.976 1.117 1.258 1.470 72 0.654 0.865 1.006 1.147 1.358
35 0.760 0.972 1.113 1.254 1.465 73 0.645 0.856 0.997 1.138 1.349
36 0.756 0.968 1.109 1.249 1.461 74 0.635 0.846 0.987 1.128 1.339
37 0.753 0.964 1.105 1.246 1.457 75 0.624 0.835 0.976 1.117 1.328
38 0.749 0.960 1.101 1.242 1.454 76 0.612 0.823 0.964 1.105 1.316
39 0.746 0.957 1.098 1.239 1.451 77 0.599 0.810 0.951 1.092 1.303
40 0.743 0.955 1.095 1.236 1.448 78 0.584 0.796 0.936 1.077 1.289
41 0.741 0.952 1.093 1.234 1.445 79 0.568 0.780 0.921 1.062 1.273
42 0.738 0.950 1.091 1.232 1.443 80 0.551 0.763 0.904 1.045 1.256
43 0.736 0.948 1.089 1.230 1.441
44 0.735 0.946 1.087 1.228 1.439
S67salud pública de méxico / vol. 51, suplemento 1 de 2009
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.696 1.083 1.341 1.599 1.986 45 1.534 1.921 2.179 2.437 2.824
8 0.780 1.167 1.425 1.683 2.070 46 1.531 1.918 2.176 2.434 2.820
9 0.860 1.246 1.504 1.762 2.149 47 1.528 1.915 2.173 2.431 2.818
10 0.934 1.321 1.579 1.837 2.224 48 1.525 1.912 2.170 2.428 2.815
11 1.005 1.392 1.649 1.907 2.294 49 1.523 1.910 2.167 2.425 2.812
12 1.070 1.457 1.715 1.973 2.360 50 1.520 1.907 2.165 2.423 2.810
13 1.131 1.518 1.776 2.034 2.421 51 1.518 1.905 2.163 2.421 2.808
14 1.188 1.575 1.833 2.091 2.477 52 1.517 1.904 2.162 2.419 2.806
15 1.240 1.627 1.885 2.143 2.529 53 1.516 1.903 2.160 2.418 2.805
16 1.287 1.674 1.932 2.190 2.577 54 1.515 1.902 2.160 2.418 2.804
17 1.330 1.717 1.975 2.233 2.619 55 1.515 1.902 2.160 2.418 2.804
18 1.368 1.755 2.013 2.271 2.658 56 1.516 1.902 2.160 2.418 2.805
19 1.402 1.789 2.047 2.305 2.691 57 1.517 1.904 2.162 2.419 2.806
20 1.431 1.818 2.076 2.334 2.721 58 1.519 1.906 2.164 2.421 2.808
21 1.456 1.843 2.101 2.359 2.745 59 1.522 1.909 2.166 2.424 2.811
22 1.477 1.864 2.122 2.380 2.767 60 1.525 1.912 2.170 2.428 2.815
23 1.495 1.882 2.139 2.397 2.784 61 1.530 1.917 2.175 2.433 2.819
24 1.509 1.896 2.154 2.412 2.799 62 1.536 1.923 2.180 2.438 2.825
25 1.521 1.908 2.166 2.424 2.810 63 1.542 1.929 2.187 2.445 2.832
26 1.530 1.917 2.175 2.433 2.820 64 1.550 1.937 2.195 2.453 2.840
27 1.538 1.925 2.182 2.440 2.827 65 1.559 1.946 2.204 2.462 2.848
28 1.544 1.930 2.188 2.446 2.833 66 1.568 1.955 2.213 2.471 2.858
29 1.548 1.935 2.193 2.451 2.837 67 1.577 1.964 2.222 2.480 2.867
30 1.551 1.938 2.196 2.454 2.841 68 1.585 1.972 2.230 2.488 2.875
31 1.554 1.941 2.199 2.457 2.843 69 1.591 1.978 2.236 2.494 2.881
32 1.556 1.943 2.201 2.458 2.845 70 1.595 1.982 2.240 2.498 2.884
33 1.557 1.944 2.202 2.459 2.846 71 1.595 1.982 2.240 2.498 2.885
34 1.557 1.944 2.202 2.460 2.847 72 1.592 1.979 2.236 2.494 2.881
35 1.557 1.944 2.202 2.460 2.846 73 1.583 1.970 2.228 2.486 2.873
36 1.556 1.943 2.201 2.459 2.846 74 1.570 1.957 2.214 2.472 2.859
37 1.555 1.942 2.200 2.458 2.844 75 1.550 1.937 2.194 2.452 2.839
38 1.553 1.940 2.198 2.456 2.843 76 1.523 1.910 2.168 2.425 2.812
39 1.551 1.938 2.196 2.454 2.841 77 1.488 1.875 2.133 2.391 2.778
40 1.549 1.936 2.194 2.451 2.838 78 1.445 1.832 2.090 2.348 2.735
41 1.546 1.933 2.191 2.449 2.836 79 1.393 1.780 2.038 2.296 2.683
42 1.543 1.930 2.188 2.446 2.833 80 1.331 1.718 1.976 2.234 2.621
43 1.540 1.927 2.185 2.443 2.830
44 1.537 1.924 2.182 2.440 2.827
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.218 0.396 0.514 0.632 0.809 45 0.688 0.866 0.984 1.102 1.280
8 0.270 0.448 0.566 0.684 0.862 46 0.687 0.864 0.982 1.101 1.278
9 0.319 0.497 0.615 0.733 0.911 47 0.685 0.863 0.981 1.099 1.276
10 0.365 0.543 0.661 0.779 0.957 48 0.683 0.861 0.979 1.097 1.275
11 0.408 0.586 0.704 0.822 0.999 49 0.681 0.859 0.977 1.095 1.273
12 0.448 0.625 0.744 0.862 1.039 50 0.679 0.857 0.975 1.093 1.271
13 0.485 0.662 0.780 0.898 1.076 51 0.677 0.855 0.973 1.091 1.268
14 0.518 0.695 0.814 0.932 1.109 52 0.675 0.852 0.970 1.089 1.266
15 0.548 0.726 0.844 0.962 1.140 53 0.672 0.850 0.968 1.086 1.263
16 0.576 0.753 0.871 0.990 1.167 54 0.670 0.847 0.965 1.083 1.261
17 0.600 0.777 0.895 1.014 1.191 55 0.667 0.844 0.962 1.081 1.258
18 0.621 0.798 0.916 1.035 1.212 56 0.664 0.841 0.959 1.078 1.255
19 0.639 0.816 0.934 1.053 1.230 57 0.661 0.838 0.956 1.074 1.252
20 0.654 0.831 0.949 1.067 1.245 58 0.657 0.835 0.953 1.071 1.248
21 0.666 0.843 0.961 1.079 1.257 59 0.654 0.831 0.949 1.068 1.245
22 0.675 0.852 0.971 1.089 1.266 60 0.650 0.827 0.946 1.064 1.241
23 0.682 0.860 0.978 1.096 1.274 61 0.646 0.824 0.942 1.060 1.237
24 0.688 0.865 0.983 1.102 1.279 62 0.642 0.820 0.938 1.056 1.233
25 0.691 0.869 0.987 1.105 1.283 63 0.638 0.815 0.934 1.052 1.229
26 0.694 0.871 0.990 1.108 1.285 64 0.634 0.811 0.929 1.048 1.225
27 0.695 0.873 0.991 1.109 1.287 65 0.629 0.807 0.925 1.043 1.220
28 0.696 0.874 0.992 1.110 1.287 66 0.625 0.802 0.920 1.038 1.216
29 0.697 0.874 0.992 1.110 1.288 67 0.620 0.797 0.916 1.034 1.211
30 0.697 0.874 0.992 1.111 1.288 68 0.615 0.793 0.911 1.029 1.207
31 0.697 0.874 0.993 1.111 1.288 69 0.611 0.788 0.907 1.025 1.202
32 0.697 0.874 0.993 1.111 1.288 70 0.607 0.784 0.902 1.021 1.198
33 0.697 0.874 0.993 1.111 1.288 71 0.603 0.781 0.899 1.017 1.194
34 0.697 0.874 0.993 1.111 1.288 72 0.600 0.777 0.895 1.014 1.191
35 0.697 0.874 0.992 1.111 1.288 73 0.597 0.775 0.893 1.011 1.188
36 0.696 0.874 0.992 1.110 1.288 74 0.595 0.772 0.891 1.009 1.186
37 0.696 0.873 0.992 1.110 1.287 75 0.594 0.771 0.889 1.008 1.185
38 0.695 0.873 0.991 1.109 1.287 76 0.591 0.769 0.887 1.005 1.183
39 0.695 0.872 0.990 1.109 1.286 77 0.589 0.767 0.885 1.003 1.181
40 0.694 0.871 0.990 1.108 1.285 78 0.587 0.765 0.883 1.001 1.179
41 0.693 0.871 0.989 1.107 1.284 79 0.585 0.763 0.881 0.999 1.177
42 0.692 0.870 0.988 1.106 1.283 80 0.583 0.761 0.879 0.997 1.175
43 0.691 0.868 0.987 1.105 1.282
44 0.690 0.867 0.985 1.104 1.281
Table IV.5
Bone Mineral density Z score values of arM for Male PoPulation
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.408 0.590 0.711 0.832 1.014 45 1.005 1.187 1.308 1.429 1.611
8 0.493 0.675 0.797 0.918 1.100 46 1.004 1.186 1.307 1.429 1.611
9 0.573 0.755 0.876 0.998 1.180 47 1.003 1.185 1.306 1.428 1.610
10 0.647 0.829 0.950 1.072 1.254 48 1.002 1.184 1.306 1.427 1.609
11 0.715 0.897 1.019 1.140 1.322 49 1.001 1.184 1.305 1.426 1.608
12 0.777 0.960 1.081 1.202 1.384 50 1.001 1.183 1.304 1.426 1.608
13 0.834 1.016 1.137 1.259 1.441 51 1.000 1.182 1.304 1.425 1.607
14 0.885 1.067 1.188 1.310 1.492 52 0.999 1.182 1.303 1.424 1.606
15 0.930 1.112 1.233 1.355 1.537 53 0.999 1.181 1.302 1.424 1.606
16 0.969 1.151 1.273 1.394 1.576 54 0.998 1.180 1.301 1.423 1.605
17 1.002 1.185 1.306 1.427 1.609 55 0.997 1.179 1.300 1.422 1.604
18 1.030 1.212 1.334 1.455 1.637 56 0.996 1.178 1.299 1.421 1.603
19 1.052 1.234 1.355 1.477 1.659 57 0.994 1.177 1.298 1.419 1.601
20 1.068 1.250 1.372 1.493 1.675 58 0.993 1.175 1.296 1.418 1.600
21 1.079 1.261 1.383 1.504 1.686 59 0.991 1.173 1.295 1.416 1.598
22 1.086 1.268 1.389 1.510 1.692 60 0.989 1.171 1.293 1.414 1.596
23 1.088 1.270 1.392 1.513 1.695 61 0.987 1.169 1.290 1.412 1.594
24 1.088 1.270 1.391 1.512 1.694 62 0.984 1.166 1.288 1.409 1.591
25 1.084 1.266 1.388 1.509 1.691 63 0.981 1.163 1.285 1.406 1.588
26 1.079 1.261 1.383 1.504 1.686 64 0.978 1.160 1.281 1.403 1.585
27 1.073 1.255 1.376 1.498 1.680 65 0.974 1.156 1.278 1.399 1.581
28 1.066 1.248 1.369 1.490 1.672 66 0.970 1.152 1.273 1.395 1.577
29 1.058 1.240 1.362 1.483 1.665 67 0.965 1.148 1.269 1.390 1.572
30 1.052 1.234 1.355 1.477 1.659 68 0.961 1.143 1.264 1.385 1.567
31 1.046 1.228 1.349 1.470 1.653 69 0.955 1.138 1.259 1.380 1.562
32 1.040 1.222 1.344 1.465 1.647 70 0.950 1.132 1.253 1.375 1.557
33 1.035 1.217 1.339 1.460 1.642 71 0.944 1.126 1.248 1.369 1.551
34 1.031 1.213 1.334 1.455 1.637 72 0.938 1.120 1.242 1.363 1.545
35 1.026 1.209 1.330 1.451 1.633 73 0.932 1.114 1.236 1.357 1.539
36 1.023 1.205 1.326 1.448 1.630 74 0.926 1.108 1.229 1.351 1.533
37 1.020 1.202 1.323 1.444 1.626 75 0.919 1.102 1.223 1.344 1.526
38 1.017 1.199 1.320 1.441 1.624 76 0.913 1.095 1.216 1.338 1.520
39 1.014 1.196 1.318 1.439 1.621 77 0.906 1.088 1.210 1.331 1.513
40 1.012 1.194 1.315 1.437 1.619 78 0.899 1.082 1.203 1.324 1.506
41 1.010 1.192 1.313 1.435 1.617 79 0.893 1.075 1.196 1.318 1.500
42 1.008 1.190 1.312 1.433 1.615 80 0.886 1.068 1.189 1.311 1.493
43 1.007 1.189 1.310 1.432 1.614
44 1.006 1.188 1.309 1.430 1.613
Artículo originAl
S70 salud pública de méxico / vol. 51, suplemento 1 de 2009
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.341 0.483 0.578 0.673 0.816 45 0.776 0.919 1.014 1.109 1.251
8 0.396 0.538 0.633 0.728 0.870 46 0.775 0.918 1.013 1.108 1.250
9 0.447 0.589 0.684 0.779 0.922 47 0.775 0.917 1.012 1.107 1.250
10 0.494 0.637 0.732 0.827 0.969 48 0.774 0.916 1.011 1.106 1.249
11 0.538 0.681 0.776 0.871 1.013 49 0.773 0.916 1.011 1.106 1.248
12 0.579 0.722 0.817 0.911 1.054 50 0.772 0.915 1.010 1.105 1.247
13 0.616 0.759 0.854 0.949 1.091 51 0.772 0.914 1.009 1.104 1.247
14 0.650 0.792 0.887 0.982 1.125 52 0.771 0.913 1.008 1.103 1.246
15 0.680 0.823 0.918 1.013 1.155 53 0.770 0.913 1.008 1.102 1.245
16 0.707 0.849 0.944 1.039 1.182 54 0.769 0.912 1.007 1.102 1.244
17 0.730 0.873 0.968 1.063 1.205 55 0.768 0.911 1.006 1.101 1.243
18 0.750 0.892 0.987 1.082 1.225 56 0.768 0.910 1.005 1.100 1.243
19 0.766 0.909 1.004 1.099 1.241 57 0.767 0.909 1.004 1.099 1.242
20 0.779 0.922 1.017 1.112 1.254 58 0.766 0.908 1.003 1.098 1.241
21 0.789 0.931 1.026 1.121 1.264 59 0.765 0.907 1.002 1.097 1.240
22 0.796 0.938 1.033 1.128 1.271 60 0.764 0.906 1.001 1.096 1.239
23 0.801 0.943 1.038 1.133 1.275 61 0.763 0.905 1.000 1.095 1.238
24 0.803 0.946 1.041 1.136 1.278 62 0.762 0.904 0.999 1.094 1.236
25 0.804 0.946 1.041 1.136 1.279 63 0.760 0.903 0.998 1.093 1.235
26 0.804 0.946 1.041 1.136 1.279 64 0.759 0.901 0.996 1.091 1.234
27 0.802 0.945 1.040 1.135 1.277 65 0.758 0.900 0.995 1.090 1.232
28 0.800 0.943 1.038 1.133 1.275 66 0.756 0.898 0.993 1.088 1.231
29 0.798 0.941 1.036 1.131 1.273 67 0.754 0.897 0.991 1.086 1.229
30 0.796 0.939 1.034 1.129 1.271 68 0.752 0.894 0.989 1.084 1.227
31 0.794 0.937 1.032 1.127 1.269 69 0.749 0.891 0.986 1.081 1.224
32 0.792 0.935 1.030 1.125 1.267 70 0.746 0.888 0.983 1.078 1.220
33 0.791 0.933 1.028 1.123 1.265 71 0.741 0.884 0.979 1.074 1.216
34 0.789 0.931 1.026 1.121 1.264 72 0.736 0.879 0.974 1.069 1.211
35 0.787 0.930 1.025 1.120 1.262 73 0.731 0.873 0.968 1.063 1.206
36 0.786 0.928 1.023 1.118 1.261 74 0.724 0.866 0.961 1.056 1.199
37 0.785 0.927 1.022 1.117 1.259 75 0.716 0.858 0.953 1.048 1.191
38 0.783 0.926 1.021 1.116 1.258 76 0.707 0.849 0.944 1.039 1.181
39 0.782 0.925 1.020 1.115 1.257 77 0.696 0.839 0.934 1.028 1.171
40 0.781 0.924 1.019 1.113 1.256 78 0.684 0.827 0.922 1.016 1.159
41 0.780 0.922 1.017 1.112 1.255 79 0.671 0.813 0.908 1.003 1.145
42 0.779 0.921 1.016 1.111 1.254 80 0.655 0.798 0.893 0.988 1.130
43 0.778 0.921 1.016 1.110 1.253
44 0.777 0.920 1.015 1.110 1.252
S71salud pública de méxico / vol. 51, suplemento 1 de 2009
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.336 0.447 0.522 0.596 0.708 45 0.589 0.700 0.775 0.849 2.766
8 0.368 0.480 0.554 0.629 0.708 46 0.588 0.700 0.774 0.849 2.763
9 0.399 0.511 0.585 0.660 0.585 47 0.587 0.699 0.774 0.848 2.761
10 0.428 0.539 0.614 0.688 0.614 48 0.587 0.698 0.773 0.847 2.759
11 0.454 0.566 0.640 0.715 1.998 49 0.586 0.698 0.772 0.847 2.757
12 0.478 0.590 0.664 0.739 2.102 50 0.586 0.697 0.772 0.846 2.754
13 0.500 0.612 0.687 0.761 2.200 51 0.585 0.697 0.771 0.846 2.752
14 0.521 0.632 0.707 0.781 2.290 52 0.585 0.696 0.771 0.845 2.750
15 0.539 0.650 0.725 0.799 2.374 53 0.584 0.696 0.770 0.845 2.748
16 0.554 0.666 0.741 0.815 2.450 54 0.583 0.695 0.770 0.844 2.747
17 0.568 0.680 0.754 0.829 2.519 55 0.583 0.694 0.769 0.843 2.745
18 0.580 0.692 0.766 0.840 2.581 56 0.582 0.694 0.768 0.843 2.743
19 0.589 0.701 0.775 0.850 2.635 57 0.581 0.693 0.768 0.842 2.741
20 0.597 0.708 0.783 0.857 2.683 58 0.581 0.693 0.767 0.841 2.739
21 0.602 0.714 0.788 0.863 2.723 59 0.580 0.692 0.766 0.841 2.736
22 0.606 0.718 0.792 0.867 2.756 60 0.579 0.691 0.766 0.840 2.734
23 0.609 0.720 0.795 0.869 2.782 61 0.579 0.690 0.765 0.839 2.732
24 0.610 0.721 0.796 0.870 2.802 62 0.578 0.689 0.764 0.838 2.729
25 0.610 0.722 0.796 0.871 2.815 63 0.577 0.689 0.763 0.837 2.726
26 0.609 0.721 0.796 0.870 2.824 64 0.576 0.688 0.762 0.837 2.724
27 0.608 0.720 0.794 0.869 2.829 65 0.575 0.687 0.761 0.836 2.721
28 0.607 0.718 0.793 0.867 2.830 66 0.574 0.685 0.760 0.834 2.717
29 0.605 0.717 0.791 0.866 2.829 67 0.572 0.684 0.759 0.833 2.714
30 0.603 0.715 0.790 0.864 2.826 68 0.571 0.683 0.757 0.832 2.710
31 0.602 0.714 0.788 0.863 2.821 69 0.569 0.681 0.755 0.830 2.706
32 0.601 0.712 0.787 0.861 2.816 70 0.567 0.679 0.753 0.828 2.701
33 0.599 0.711 0.785 0.860 2.811 71 0.565 0.677 0.751 0.826 2.696
34 0.598 0.710 0.784 0.859 2.806 72 0.562 0.674 0.748 0.823 2.689
35 0.597 0.709 0.783 0.858 2.801 73 0.559 0.671 0.745 0.820 2.682
36 0.596 0.708 0.782 0.856 2.797 74 0.556 0.667 0.742 0.816 2.674
37 0.595 0.706 0.781 0.855 2.792 75 0.552 0.663 0.738 0.812 2.664
38 0.594 0.706 0.780 0.855 2.788 76 0.547 0.659 0.733 0.808 2.653
39 0.593 0.705 0.779 0.854 2.785 77 0.542 0.654 0.728 0.802 2.640
40 0.592 0.704 0.778 0.853 2.781 78 0.536 0.648 0.722 0.797 2.625
41 0.591 0.703 0.778 0.852 2.778 79 0.529 0.641 0.716 0.790 2.609
42 0.591 0.702 0.777 0.851 2.774 80 0.522 0.634 0.708 0.783 2.590
43 0.590 0.702 0.776 0.851 2.771
44 0.589 0.701 0.775 0.850 2.769
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.318 0.520 0.654 0.789 0.991 45 0.877 1.079 1.213 1.348 1.549
8 0.394 0.595 0.730 0.864 1.066 46 0.875 1.077 1.212 1.346 1.548
9 0.464 0.666 0.800 0.934 1.136 47 0.874 1.076 1.210 1.344 1.546
10 0.529 0.731 0.865 1.000 1.202 48 0.872 1.074 1.209 1.343 1.545
11 0.590 0.791 0.926 1.060 1.262 49 0.871 1.073 1.207 1.341 1.543
12 0.645 0.847 0.981 1.116 1.317 50 0.869 1.071 1.205 1.340 1.542
13 0.696 0.897 1.032 1.166 1.368 51 0.868 1.069 1.204 1.338 1.540
14 0.741 0.943 1.077 1.212 1.414 52 0.866 1.068 1.202 1.337 1.538
15 0.782 0.984 1.118 1.253 1.454 53 0.864 1.066 1.200 1.335 1.537
16 0.818 1.019 1.154 1.288 1.490 54 0.863 1.064 1.199 1.333 1.535
17 0.849 1.050 1.185 1.319 1.521 55 0.861 1.062 1.197 1.331 1.533
18 0.874 1.076 1.211 1.345 1.547 56 0.859 1.060 1.195 1.329 1.531
19 0.895 1.097 1.231 1.366 1.568 57 0.856 1.058 1.193 1.327 1.529
20 0.911 1.113 1.247 1.382 1.584 58 0.854 1.056 1.190 1.325 1.526
21 0.923 1.125 1.259 1.394 1.595 59 0.852 1.053 1.188 1.322 1.524
22 0.931 1.132 1.267 1.401 1.603 60 0.849 1.050 1.185 1.319 1.521
23 0.935 1.137 1.271 1.406 1.607 61 0.846 1.048 1.182 1.316 1.518
24 0.937 1.138 1.273 1.407 1.609 62 0.843 1.044 1.179 1.313 1.515
25 0.936 1.138 1.272 1.407 1.608 63 0.839 1.041 1.175 1.310 1.511
26 0.933 1.135 1.270 1.404 1.606 64 0.836 1.037 1.172 1.306 1.508
27 0.930 1.131 1.266 1.400 1.602 65 0.832 1.033 1.168 1.302 1.504
28 0.925 1.127 1.261 1.396 1.597 66 0.827 1.029 1.163 1.298 1.499
29 0.921 1.122 1.257 1.391 1.593 67 0.822 1.024 1.159 1.293 1.495
30 0.916 1.118 1.252 1.387 1.588 68 0.817 1.019 1.153 1.288 1.489
31 0.912 1.114 1.248 1.383 1.584 69 0.811 1.013 1.147 1.282 1.483
32 0.908 1.110 1.244 1.379 1.580 70 0.804 1.006 1.141 1.275 1.477
33 0.905 1.106 1.241 1.375 1.577 71 0.797 0.999 1.133 1.268 1.469
34 0.901 1.103 1.237 1.372 1.573 72 0.789 0.990 1.125 1.259 1.461
35 0.898 1.100 1.234 1.369 1.570 73 0.780 0.981 1.116 1.250 1.452
36 0.895 1.097 1.231 1.366 1.568 74 0.769 0.971 1.105 1.240 1.441
37 0.893 1.094 1.229 1.363 1.565 75 0.758 0.960 1.094 1.228 1.430
38 0.890 1.092 1.226 1.361 1.563 76 0.745 0.947 1.081 1.216 1.418
39 0.888 1.090 1.224 1.359 1.560 77 0.732 0.933 1.068 1.202 1.404
40 0.886 1.088 1.222 1.356 1.558 78 0.716 0.918 1.052 1.187 1.389
41 0.884 1.086 1.220 1.354 1.556 79 0.700 0.901 1.036 1.170 1.372
42 0.882 1.084 1.218 1.353 1.554 80 0.682 0.883 1.018 1.152 1.354
43 0.880 1.082 1.216 1.351 1.553
44 0.879 1.080 1.215 1.349 1.551
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.622 0.741 0.820 0.899 1.018 45 0.949 1.067 1.147 1.226 1.345
8 0.661 0.780 0.859 0.938 1.057 46 0.945 1.064 1.143 1.222 1.341
9 0.697 0.816 0.895 0.975 1.093 47 0.941 1.059 1.139 1.218 1.337
10 0.732 0.850 0.930 1.009 1.128 48 0.936 1.055 1.134 1.214 1.332
11 0.764 0.882 0.962 1.041 1.160 49 0.932 1.051 1.130 1.209 1.328
12 0.793 0.912 0.991 1.071 1.189 50 0.927 1.046 1.125 1.204 1.323
13 0.821 0.940 1.019 1.098 1.217 51 0.922 1.041 1.120 1.199 1.318
14 0.846 0.965 1.044 1.123 1.242 52 0.917 1.036 1.115 1.194 1.313
15 0.869 0.988 1.067 1.146 1.265 53 0.911 1.030 1.110 1.189 1.308
16 0.889 1.008 1.087 1.167 1.285 54 0.906 1.025 1.104 1.183 1.302
17 0.907 1.026 1.106 1.185 1.304 55 0.900 1.019 1.098 1.178 1.296
18 0.923 1.042 1.121 1.201 1.320 56 0.894 1.013 1.092 1.172 1.291
19 0.937 1.056 1.135 1.214 1.333 57 0.888 1.007 1.086 1.166 1.284
20 0.948 1.067 1.147 1.226 1.345 58 0.882 1.001 1.080 1.159 1.278
21 0.958 1.077 1.156 1.235 1.354 59 0.875 0.994 1.074 1.153 1.272
22 0.965 1.084 1.163 1.242 1.361 60 0.869 0.988 1.067 1.146 1.265
23 0.971 1.090 1.169 1.248 1.367 61 0.862 0.981 1.060 1.139 1.258
24 0.975 1.094 1.173 1.252 1.371 62 0.855 0.974 1.053 1.132 1.251
25 0.978 1.097 1.176 1.255 1.374 63 0.848 0.967 1.046 1.125 1.244
26 0.980 1.099 1.178 1.257 1.376 64 0.841 0.959 1.039 1.118 1.237
27 0.981 1.100 1.179 1.258 1.377 65 0.833 0.952 1.031 1.110 1.229
28 0.982 1.100 1.180 1.259 1.378 66 0.826 0.944 1.024 1.103 1.222
29 0.982 1.100 1.180 1.259 1.378 67 0.818 0.937 1.016 1.095 1.214
30 0.981 1.100 1.179 1.259 1.377 68 0.811 0.929 1.009 1.088 1.207
31 0.981 1.100 1.179 1.258 1.377 69 0.803 0.922 1.001 1.081 1.200
32 0.980 1.099 1.178 1.257 1.376 70 0.796 0.915 0.994 1.074 1.193
33 0.979 1.098 1.177 1.256 1.375 71 0.790 0.909 0.988 1.067 1.186
34 0.978 1.096 1.176 1.255 1.374 72 0.784 0.903 0.982 1.061 1.180
35 0.976 1.095 1.174 1.253 1.372 73 0.778 0.897 0.976 1.056 1.175
36 0.974 1.093 1.172 1.252 1.370 74 0.774 0.892 0.972 1.051 1.170
37 0.972 1.091 1.170 1.250 1.369 75 0.770 0.888 0.968 1.047 1.166
38 0.970 1.089 1.168 1.247 1.366 76 0.766 0.885 0.964 1.044 1.163
39 0.968 1.087 1.166 1.245 1.364 77 0.764 0.883 0.962 1.041 1.160
40 0.965 1.084 1.163 1.242 1.361 78 0.763 0.882 0.961 1.040 1.159
41 0.962 1.081 1.160 1.240 1.358 79 0.761 0.880 0.959 1.038 1.157
42 0.959 1.078 1.157 1.236 1.355 80 0.759 0.878 0.957 1.036 1.155
43 0.956 1.075 1.154 1.233 1.352
44 0.952 1.071 1.150 1.230 1.349
Artículo originAl
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.315 0.517 0.652 0.787 0.988 45 0.782 0.984 1.118 1.253 1.455
8 0.368 0.570 0.705 0.839 1.041 46 0.774 0.976 1.111 1.245 1.447
9 0.418 0.620 0.755 0.889 1.091 47 0.766 0.968 1.102 1.237 1.439
10 0.465 0.667 0.802 0.936 1.138 48 0.758 0.960 1.094 1.229 1.431
11 0.509 0.711 0.846 0.980 1.182 49 0.749 0.951 1.086 1.220 1.422
12 0.550 0.752 0.887 1.021 1.223 50 0.741 0.942 1.077 1.212 1.414
13 0.589 0.791 0.925 1.060 1.262 51 0.732 0.934 1.068 1.203 1.405
14 0.624 0.826 0.961 1.095 1.297 52 0.723 0.925 1.059 1.194 1.396
15 0.657 0.859 0.993 1.128 1.330 53 0.714 0.916 1.051 1.185 1.387
16 0.686 0.888 1.023 1.158 1.359 54 0.705 0.907 1.042 1.176 1.378
17 0.713 0.915 1.050 1.184 1.386 55 0.696 0.898 1.033 1.167 1.369
18 0.737 0.939 1.074 1.208 1.410 56 0.687 0.889 1.024 1.158 1.360
19 0.758 0.960 1.095 1.229 1.431 57 0.678 0.880 1.015 1.149 1.351
20 0.776 0.978 1.113 1.247 1.449 58 0.670 0.871 1.006 1.141 1.343
21 0.792 0.994 1.128 1.263 1.465 59 0.661 0.863 0.997 1.132 1.334
22 0.805 1.007 1.141 1.276 1.478 60 0.652 0.854 0.989 1.124 1.325
23 0.816 1.018 1.152 1.287 1.489 61 0.644 0.846 0.981 1.115 1.317
24 0.825 1.026 1.161 1.296 1.498 62 0.636 0.838 0.973 1.107 1.309
25 0.831 1.033 1.168 1.303 1.504 63 0.628 0.830 0.965 1.099 1.301
26 0.837 1.039 1.173 1.308 1.510 64 0.621 0.823 0.957 1.092 1.294
27 0.841 1.042 1.177 1.312 1.514 65 0.614 0.815 0.950 1.085 1.287
28 0.843 1.045 1.180 1.314 1.516 66 0.607 0.809 0.943 1.078 1.280
29 0.845 1.047 1.181 1.316 1.518 67 0.600 0.802 0.936 1.071 1.273
30 0.845 1.047 1.182 1.317 1.519 68 0.594 0.795 0.930 1.065 1.267
31 0.845 1.047 1.182 1.317 1.518 69 0.587 0.789 0.924 1.058 1.260
32 0.845 1.047 1.181 1.316 1.518 70 0.581 0.783 0.918 1.052 1.254
33 0.843 1.045 1.180 1.314 1.516 71 0.575 0.777 0.912 1.046 1.248
34 0.841 1.043 1.178 1.312 1.514 72 0.570 0.771 0.906 1.041 1.243
35 0.838 1.040 1.175 1.309 1.511 73 0.564 0.766 0.900 1.035 1.237
36 0.835 1.037 1.171 1.306 1.508 74 0.558 0.760 0.895 1.029 1.231
37 0.831 1.033 1.167 1.302 1.504 75 0.553 0.755 0.889 1.024 1.226
38 0.826 1.028 1.163 1.297 1.499 76 0.547 0.749 0.884 1.018 1.220
39 0.821 1.023 1.158 1.292 1.494 77 0.541 0.743 0.878 1.012 1.214
40 0.816 1.018 1.152 1.287 1.489 78 0.536 0.738 0.872 1.007 1.209
41 0.810 1.012 1.146 1.281 1.483 79 0.530 0.732 0.866 1.001 1.203
42 0.803 1.005 1.140 1.274 1.476 80 0.524 0.726 0.860 0.995 1.197
43 0.796 0.998 1.133 1.268 1.469
44 0.789 0.991 1.126 1.260 1.462
S75salud pública de méxico / vol. 51, suplemento 1 de 2009
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.444 0.623 0.743 0.863 1.042 45 0.714 0.893 1.013 1.133 1.312
8 0.483 0.662 0.782 0.902 1.081 46 0.710 0.889 1.009 1.129 1.308
9 0.519 0.699 0.819 0.938 1.118 47 0.706 0.885 1.005 1.125 1.304
10 0.554 0.733 0.853 0.972 1.152 48 0.701 0.881 1.001 1.120 1.300
11 0.585 0.765 0.884 1.004 1.183 49 0.697 0.877 0.996 1.116 1.295
12 0.614 0.793 0.913 1.033 1.212 50 0.692 0.872 0.992 1.111 1.291
13 0.640 0.820 0.940 1.059 1.239 51 0.688 0.867 0.987 1.106 1.286
14 0.664 0.844 0.964 1.083 1.263 52 0.682 0.862 0.982 1.101 1.281
15 0.686 0.865 0.985 1.105 1.284 53 0.677 0.857 0.976 1.096 1.276
16 0.705 0.884 1.004 1.124 1.303 54 0.672 0.851 0.971 1.091 1.270
17 0.721 0.901 1.020 1.140 1.319 55 0.666 0.846 0.965 1.085 1.264
18 0.735 0.914 1.034 1.154 1.333 56 0.660 0.840 0.959 1.079 1.259
19 0.746 0.926 1.045 1.165 1.345 57 0.654 0.833 0.953 1.073 1.252
20 0.755 0.935 1.054 1.174 1.354 58 0.648 0.827 0.947 1.066 1.246
21 0.762 0.941 1.061 1.181 1.360 59 0.641 0.820 0.940 1.060 1.239
22 0.766 0.946 1.066 1.185 1.365 60 0.634 0.813 0.933 1.053 1.232
23 0.769 0.949 1.068 1.188 1.368 61 0.627 0.806 0.926 1.046 1.225
24 0.770 0.950 1.070 1.189 1.369 62 0.619 0.799 0.918 1.038 1.218
25 0.770 0.950 1.070 1.189 1.369 63 0.611 0.791 0.911 1.030 1.210
26 0.770 0.949 1.069 1.188 1.368 64 0.603 0.783 0.903 1.022 1.202
27 0.768 0.947 1.067 1.187 1.366 65 0.595 0.774 0.894 1.014 1.193
28 0.765 0.945 1.065 1.184 1.364 66 0.586 0.766 0.886 1.005 1.185
29 0.763 0.942 1.062 1.182 1.361 67 0.578 0.757 0.877 0.997 1.176
30 0.760 0.940 1.060 1.179 1.359 68 0.569 0.749 0.868 0.988 1.168
31 0.758 0.937 1.057 1.177 1.356 69 0.561 0.740 0.860 0.980 1.159
32 0.755 0.935 1.054 1.174 1.354 70 0.552 0.732 0.852 0.971 1.151
33 0.752 0.932 1.052 1.171 1.351 71 0.545 0.724 0.844 0.963 1.143
34 0.750 0.929 1.049 1.169 1.348 72 0.537 0.717 0.836 0.956 1.136
35 0.747 0.926 1.046 1.166 1.345 73 0.530 0.710 0.829 0.949 1.129
36 0.744 0.924 1.043 1.163 1.342 74 0.524 0.704 0.823 0.943 1.123
37 0.741 0.921 1.040 1.160 1.339 75 0.519 0.698 0.818 0.938 1.117
38 0.738 0.918 1.037 1.157 1.336 76 0.514 0.694 0.814 0.933 1.113
39 0.735 0.914 1.034 1.154 1.333 77 0.511 0.691 0.810 0.930 1.109
40 0.732 0.911 1.031 1.151 1.330 78 0.509 0.688 0.808 0.928 1.107
41 0.728 0.908 1.028 1.147 1.327 79 0.507 0.686 0.806 0.926 1.105
42 0.725 0.905 1.024 1.144 1.323 80 0.505 0.684 0.804 0.924 1.103
43 0.721 0.901 1.021 1.140 1.320
44 0.718 0.897 1.017 1.137 1.316
Artículo originAl
S76 salud pública de méxico / vol. 51, suplemento 1 de 2009
Tamayo J y col.
Table IV.13





-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.637 1.048 1.322 1.597 2.008 45 1.697 2.108 2.382 2.657 3.068
8 0.744 1.156 1.430 1.704 2.116 46 1.685 2.096 2.371 2.645 3.056
9 0.846 1.258 1.532 1.806 2.217 47 1.673 2.084 2.358 2.633 3.044
10 0.942 1.354 1.628 1.902 2.314 48 1.660 2.071 2.346 2.620 3.031
11 1.033 1.444 1.719 1.993 2.404 49 1.647 2.058 2.332 2.607 3.018
12 1.118 1.529 1.804 2.078 2.489 50 1.633 2.045 2.319 2.593 3.005
13 1.197 1.608 1.883 2.157 2.568 51 1.620 2.031 2.305 2.579 2.991
14 1.271 1.682 1.956 2.231 2.642 52 1.605 2.017 2.291 2.565 2.977
15 1.339 1.750 2.024 2.298 2.710 53 1.591 2.003 2.277 2.551 2.962
16 1.401 1.812 2.086 2.361 2.772 54 1.577 1.988 2.263 2.537 2.948
17 1.457 1.869 2.143 2.417 2.828 55 1.563 1.974 2.248 2.522 2.934
18 1.508 1.919 2.194 2.468 2.879 56 1.548 1.960 2.234 2.508 2.919
19 1.553 1.965 2.239 2.513 2.925 57 1.534 1.945 2.219 2.494 2.905
20 1.593 2.004 2.278 2.553 2.964 58 1.520 1.931 2.205 2.480 2.891
21 1.627 2.039 2.313 2.587 2.998 59 1.506 1.917 2.191 2.466 2.877
22 1.657 2.068 2.342 2.616 3.028 60 1.492 1.903 2.178 2.452 2.863
23 1.682 2.093 2.367 2.641 3.053 61 1.479 1.890 2.164 2.439 2.850
24 1.703 2.114 2.388 2.662 3.074 62 1.466 1.877 2.151 2.426 2.837
25 1.720 2.131 2.406 2.680 3.091 63 1.453 1.865 2.139 2.413 2.824
26 1.734 2.145 2.420 2.694 3.105 64 1.441 1.853 2.127 2.401 2.812
27 1.745 2.157 2.431 2.705 3.117 65 1.430 1.841 2.115 2.390 2.801
28 1.754 2.166 2.440 2.714 3.125 66 1.419 1.830 2.104 2.378 2.790
29 1.761 2.172 2.447 2.721 3.132 67 1.408 1.819 2.093 2.368 2.779
30 1.766 2.178 2.452 2.726 3.138 68 1.397 1.809 2.083 2.357 2.768
31 1.770 2.181 2.456 2.730 3.141 69 1.387 1.798 2.072 2.346 2.758
32 1.772 2.184 2.458 2.732 3.144 70 1.376 1.787 2.061 2.336 2.747
33 1.773 2.185 2.459 2.733 3.144 71 1.365 1.776 2.050 2.324 2.736
34 1.773 2.184 2.458 2.733 3.144 72 1.353 1.764 2.039 2.313 2.724
35 1.771 2.182 2.457 2.731 3.142 73 1.341 1.752 2.027 2.301 2.712
36 1.768 2.179 2.454 2.728 3.139 74 1.328 1.739 2.014 2.288 2.699
37 1.764 2.175 2.450 2.724 3.135 75 1.314 1.726 2.000 2.274 2.686
38 1.759 2.170 2.444 2.719 3.130 76 1.300 1.711 1.985 2.259 2.671
39 1.753 2.164 2.438 2.712 3.124 77 1.284 1.695 1.969 2.244 2.655
40 1.745 2.157 2.431 2.705 3.117 78 1.266 1.678 1.952 2.226 2.638
41 1.737 2.149 2.423 2.697 3.108 79 1.248 1.659 1.933 2.208 2.619
42 1.728 2.140 2.414 2.688 3.099 80 1.227 1.639 1.913 2.187 2.599
43 1.718 2.130 2.404 2.678 3.090
44 1.708 2.119 2.394 2.668 3.079
S77salud pública de méxico / vol. 51, suplemento 1 de 2009
DXA normal reference values for Mexican mestizo population Artículo originAl
Table IV.14





-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.346 0.479 0.567 0.655 0.788 45 0.617 0.749 0.838 0.926 1.059
8 0.375 0.508 0.596 0.685 0.817 46 0.613 0.746 0.834 0.923 1.055
9 0.403 0.536 0.624 0.712 0.845 47 0.610 0.743 0.831 0.919 1.052
10 0.429 0.562 0.650 0.739 0.871 48 0.606 0.739 0.827 0.916 1.048
11 0.454 0.586 0.675 0.763 0.895 49 0.602 0.735 0.823 0.912 1.044
12 0.476 0.609 0.697 0.786 0.918 50 0.598 0.731 0.819 0.907 1.040
13 0.498 0.630 0.718 0.807 0.939 51 0.594 0.726 0.815 0.903 1.036
14 0.517 0.650 0.738 0.826 0.959 52 0.589 0.722 0.810 0.898 1.031
15 0.535 0.667 0.756 0.844 0.977 53 0.584 0.717 0.805 0.893 1.026
16 0.551 0.684 0.772 0.860 0.993 54 0.579 0.712 0.800 0.888 1.021
17 0.566 0.698 0.787 0.875 1.007 55 0.574 0.706 0.795 0.883 1.015
18 0.578 0.711 0.799 0.888 1.020 56 0.568 0.701 0.789 0.877 1.010
19 0.590 0.722 0.811 0.899 1.032 57 0.562 0.695 0.783 0.872 1.004
20 0.599 0.732 0.820 0.909 1.041 58 0.556 0.689 0.777 0.865 0.998
21 0.607 0.740 0.828 0.917 1.049 59 0.550 0.682 0.771 0.859 0.992
22 0.614 0.747 0.835 0.924 1.056 60 0.543 0.676 0.764 0.853 0.985
23 0.620 0.752 0.841 0.929 1.062 61 0.537 0.669 0.758 0.846 0.979
24 0.624 0.757 0.845 0.933 1.066 62 0.530 0.662 0.751 0.839 0.972
25 0.628 0.760 0.849 0.937 1.070 63 0.523 0.655 0.744 0.832 0.964
26 0.630 0.763 0.851 0.940 1.072 64 0.515 0.648 0.736 0.825 0.957
27 0.632 0.765 0.853 0.942 1.074 65 0.508 0.640 0.729 0.817 0.950
28 0.634 0.766 0.855 0.943 1.076 66 0.500 0.633 0.721 0.809 0.942
29 0.635 0.767 0.856 0.944 1.077 67 0.492 0.625 0.713 0.802 0.934
30 0.636 0.768 0.857 0.945 1.077 68 0.485 0.617 0.706 0.794 0.927
31 0.636 0.769 0.857 0.945 1.078 69 0.477 0.610 0.698 0.787 0.919
32 0.636 0.769 0.857 0.946 1.078 70 0.470 0.603 0.691 0.779 0.912
33 0.636 0.769 0.857 0.946 1.078 71 0.463 0.596 0.684 0.773 0.905
34 0.636 0.769 0.857 0.945 1.078 72 0.457 0.590 0.678 0.766 0.899
35 0.636 0.768 0.857 0.945 1.077 73 0.452 0.584 0.672 0.761 0.893
36 0.635 0.767 0.856 0.944 1.077 74 0.447 0.579 0.667 0.756 0.888
37 0.634 0.766 0.855 0.943 1.076 75 0.442 0.575 0.663 0.752 0.884
38 0.633 0.765 0.853 0.942 1.074 76 0.439 0.572 0.660 0.748 0.881
39 0.631 0.764 0.852 0.940 1.073 77 0.437 0.569 0.658 0.746 0.879
40 0.629 0.762 0.850 0.939 1.071 78 0.435 0.568 0.656 0.744 0.877
41 0.627 0.760 0.848 0.936 1.069 79 0.433 0.566 0.654 0.742 0.875
42 0.625 0.758 0.846 0.934 1.067 80 0.431 0.564 0.652 0.740 0.873
43 0.622 0.755 0.843 0.932 1.064
44 0.620 0.752 0.841 0.929 1.062
Artículo originAl
S78 salud pública de méxico / vol. 51, suplemento 1 de 2009
Tamayo J y col.
Table IV.15





-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.588 0.719 0.806 0.893 1.023 45 0.912 1.042 1.129 1.217 1.347
8 0.636 0.767 0.854 0.941 1.072 46 0.909 1.040 1.127 1.214 1.344
9 0.681 0.812 0.899 0.986 1.117 47 0.906 1.037 1.124 1.211 1.342
10 0.723 0.854 0.941 1.028 1.159 48 0.903 1.034 1.121 1.208 1.339
11 0.762 0.893 0.980 1.067 1.197 49 0.900 1.031 1.118 1.205 1.335
12 0.797 0.928 1.015 1.102 1.233 50 0.897 1.027 1.114 1.201 1.332
13 0.829 0.960 1.047 1.134 1.265 51 0.893 1.024 1.111 1.198 1.328
14 0.858 0.989 1.076 1.163 1.294 52 0.889 1.020 1.107 1.194 1.324
15 0.884 1.014 1.101 1.188 1.319 53 0.885 1.016 1.103 1.190 1.320
16 0.906 1.037 1.124 1.211 1.341 54 0.880 1.011 1.098 1.185 1.316
17 0.925 1.056 1.143 1.230 1.360 55 0.876 1.006 1.093 1.180 1.311
18 0.941 1.071 1.158 1.245 1.376 56 0.871 1.001 1.088 1.175 1.306
19 0.953 1.084 1.171 1.258 1.389 57 0.865 0.996 1.083 1.170 1.300
20 0.962 1.093 1.180 1.267 1.398 58 0.859 0.990 1.077 1.164 1.295
21 0.969 1.099 1.187 1.274 1.404 59 0.853 0.983 1.071 1.158 1.288
22 0.973 1.103 1.190 1.277 1.408 60 0.846 0.977 1.064 1.151 1.281
23 0.974 1.105 1.192 1.279 1.410 61 0.839 0.969 1.057 1.144 1.274
24 0.974 1.105 1.192 1.279 1.409 62 0.831 0.962 1.049 1.136 1.267
25 0.972 1.103 1.190 1.277 1.408 63 0.823 0.953 1.041 1.128 1.258
26 0.969 1.100 1.187 1.274 1.405 64 0.814 0.945 1.032 1.119 1.249
27 0.966 1.096 1.183 1.271 1.401 65 0.805 0.935 1.022 1.110 1.240
28 0.962 1.092 1.179 1.266 1.397 66 0.795 0.926 1.013 1.100 1.230
29 0.958 1.088 1.175 1.262 1.393 67 0.785 0.916 1.003 1.090 1.221
30 0.954 1.084 1.171 1.258 1.389 68 0.775 0.906 0.993 1.080 1.211
31 0.950 1.081 1.168 1.255 1.385 69 0.765 0.896 0.983 1.070 1.201
32 0.946 1.077 1.164 1.251 1.382 70 0.756 0.887 0.974 1.061 1.191
33 0.943 1.074 1.161 1.248 1.379 71 0.747 0.878 0.965 1.052 1.182
34 0.940 1.071 1.158 1.245 1.376 72 0.739 0.869 0.956 1.043 1.174
35 0.937 1.068 1.155 1.242 1.373 73 0.731 0.862 0.949 1.036 1.167
36 0.935 1.065 1.152 1.239 1.370 74 0.725 0.855 0.943 1.030 1.160
37 0.932 1.062 1.150 1.237 1.367 75 0.720 0.850 0.937 1.024 1.155
38 0.929 1.060 1.147 1.234 1.365 76 0.716 0.846 0.934 1.021 1.151
39 0.927 1.057 1.145 1.232 1.362 77 0.714 0.844 0.931 1.018 1.149
40 0.924 1.055 1.142 1.229 1.360 78 0.711 0.842 0.929 1.016 1.147
41 0.922 1.053 1.140 1.227 1.357 79 0.709 0.840 0.927 1.014 1.145
42 0.919 1.050 1.137 1.224 1.355 80 0.707 0.838 0.925 1.012 1.143
43 0.917 1.048 1.135 1.222 1.352
44 0.914 1.045 1.132 1.219 1.350
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.446 0.565 0.644 0.724 0.843 45 0.751 0.870 0.950 1.029 1.148
8 0.483 0.602 0.682 0.761 0.880 46 0.748 0.867 0.946 1.026 1.145
9 0.518 0.638 0.717 0.797 0.916 47 0.744 0.863 0.943 1.022 1.141
10 0.551 0.671 0.750 0.830 0.949 48 0.740 0.860 0.939 1.019 1.138
11 0.582 0.701 0.781 0.860 0.980 49 0.737 0.856 0.935 1.015 1.134
12 0.611 0.730 0.809 0.889 1.008 50 0.733 0.852 0.931 1.011 1.130
13 0.637 0.756 0.836 0.915 1.034 51 0.728 0.848 0.927 1.007 1.126
14 0.661 0.780 0.860 0.939 1.058 52 0.724 0.843 0.923 1.002 1.121
15 0.683 0.802 0.881 0.961 1.080 53 0.720 0.839 0.918 0.998 1.117
16 0.702 0.821 0.901 0.980 1.099 54 0.715 0.834 0.914 0.993 1.112
17 0.719 0.838 0.918 0.997 1.117 55 0.710 0.830 0.909 0.989 1.108
18 0.734 0.853 0.933 1.012 1.132 56 0.706 0.825 0.904 0.984 1.103
19 0.747 0.866 0.946 1.025 1.144 57 0.701 0.820 0.899 0.979 1.098
20 0.757 0.876 0.956 1.035 1.155 58 0.695 0.815 0.894 0.974 1.093
21 0.766 0.885 0.964 1.044 1.163 59 0.690 0.809 0.889 0.968 1.088
22 0.772 0.891 0.971 1.050 1.170 60 0.685 0.804 0.884 0.963 1.082
23 0.777 0.896 0.976 1.055 1.174 61 0.679 0.799 0.878 0.957 1.077
24 0.781 0.900 0.979 1.059 1.178 62 0.674 0.793 0.872 0.952 1.071
25 0.783 0.902 0.981 1.061 1.180 63 0.668 0.787 0.867 0.946 1.065
26 0.784 0.903 0.983 1.062 1.181 64 0.662 0.781 0.861 0.940 1.059
27 0.784 0.904 0.983 1.063 1.182 65 0.656 0.775 0.855 0.934 1.053
28 0.784 0.903 0.983 1.062 1.182 66 0.650 0.769 0.849 0.928 1.047
29 0.784 0.903 0.982 1.062 1.181 67 0.644 0.763 0.843 0.922 1.041
30 0.783 0.902 0.982 1.061 1.180 68 0.638 0.757 0.837 0.916 1.035
31 0.782 0.901 0.981 1.060 1.179 69 0.632 0.751 0.831 0.910 1.029
32 0.781 0.900 0.980 1.059 1.178 70 0.626 0.745 0.825 0.904 1.023
33 0.780 0.899 0.978 1.058 1.177 71 0.620 0.740 0.819 0.899 1.018
34 0.778 0.897 0.977 1.056 1.175 72 0.615 0.734 0.814 0.893 1.012
35 0.776 0.896 0.975 1.055 1.174 73 0.610 0.729 0.809 0.888 1.007
36 0.775 0.894 0.973 1.053 1.172 74 0.605 0.724 0.804 0.883 1.002
37 0.773 0.892 0.971 1.051 1.170 75 0.601 0.720 0.799 0.879 0.998
38 0.771 0.890 0.969 1.049 1.168 76 0.597 0.716 0.795 0.875 0.994
39 0.768 0.887 0.967 1.046 1.166 77 0.593 0.712 0.792 0.871 0.991
40 0.766 0.885 0.964 1.044 1.163 78 0.590 0.710 0.789 0.868 0.988
41 0.763 0.882 0.962 1.041 1.161 79 0.588 0.707 0.787 0.866 0.985
42 0.760 0.880 0.959 1.039 1.158 80 0.586 0.706 0.785 0.865 0.984
43 0.757 0.877 0.956 1.036 1.155
44 0.754 0.874 0.953 1.032 1.152
Table IV.16
Bone Mineral density Z score values of trunk for feMale PoPulation
Artículo originAl
S80 salud pública de méxico / vol. 51, suplemento 1 de 2009
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.400 0.492 0.553 0.614 0.706 45 0.565 0.657 0.718 0.780 0.872
8 0.423 0.515 0.576 0.637 0.729 46 0.563 0.655 0.717 0.778 0.870
9 0.444 0.536 0.598 0.659 0.751 47 0.562 0.653 0.715 0.776 0.868
10 0.465 0.556 0.618 0.679 0.771 48 0.560 0.652 0.713 0.774 0.866
11 0.483 0.575 0.636 0.698 0.790 49 0.558 0.650 0.711 0.772 0.864
12 0.500 0.592 0.654 0.715 0.807 50 0.556 0.648 0.709 0.770 0.862
13 0.516 0.608 0.669 0.730 0.822 51 0.553 0.645 0.707 0.768 0.860
14 0.530 0.622 0.683 0.745 0.837 52 0.551 0.643 0.704 0.766 0.858
15 0.543 0.635 0.696 0.757 0.849 53 0.549 0.641 0.702 0.763 0.855
16 0.554 0.646 0.707 0.768 0.860 54 0.546 0.638 0.700 0.761 0.853
17 0.564 0.656 0.717 0.778 0.870 55 0.544 0.636 0.697 0.758 0.850
18 0.572 0.664 0.725 0.786 0.878 56 0.541 0.633 0.694 0.756 0.848
19 0.578 0.670 0.732 0.793 0.885 57 0.538 0.630 0.692 0.753 0.845
20 0.584 0.676 0.737 0.798 0.890 58 0.536 0.627 0.689 0.750 0.842
21 0.588 0.680 0.741 0.802 0.894 59 0.532 0.624 0.686 0.747 0.839
22 0.590 0.682 0.744 0.805 0.897 60 0.529 0.621 0.683 0.744 0.836
23 0.592 0.684 0.745 0.806 0.898 61 0.526 0.618 0.679 0.741 0.832
24 0.593 0.685 0.746 0.807 0.899 62 0.523 0.615 0.676 0.737 0.829
25 0.593 0.685 0.746 0.807 0.899 63 0.519 0.611 0.672 0.733 0.825
26 0.592 0.684 0.745 0.807 0.899 64 0.515 0.607 0.668 0.730 0.822
27 0.591 0.683 0.744 0.806 0.898 65 0.511 0.603 0.665 0.726 0.818
28 0.590 0.682 0.743 0.804 0.896 66 0.507 0.599 0.661 0.722 0.814
29 0.589 0.681 0.742 0.803 0.895 67 0.503 0.595 0.656 0.718 0.810
30 0.587 0.679 0.740 0.802 0.894 68 0.499 0.591 0.652 0.713 0.805
31 0.586 0.678 0.739 0.800 0.892 69 0.494 0.586 0.648 0.709 0.801
32 0.584 0.676 0.738 0.799 0.891 70 0.490 0.582 0.643 0.705 0.796
33 0.583 0.675 0.736 0.798 0.889 71 0.485 0.577 0.639 0.700 0.792
34 0.582 0.674 0.735 0.796 0.888 72 0.481 0.573 0.634 0.695 0.787
35 0.580 0.672 0.734 0.795 0.887 73 0.476 0.568 0.629 0.691 0.783
36 0.579 0.671 0.732 0.793 0.885 74 0.471 0.563 0.625 0.686 0.778
37 0.578 0.669 0.731 0.792 0.884 75 0.467 0.559 0.620 0.681 0.773
38 0.576 0.668 0.729 0.791 0.883 76 0.462 0.554 0.615 0.677 0.769
39 0.575 0.667 0.728 0.789 0.881 77 0.457 0.549 0.611 0.672 0.764
40 0.573 0.665 0.726 0.788 0.880 78 0.453 0.545 0.606 0.667 0.759
41 0.572 0.664 0.725 0.786 0.878 79 0.448 0.540 0.601 0.663 0.755
42 0.570 0.662 0.723 0.785 0.877 80 0.443 0.535 0.597 0.658 0.750
43 0.568 0.660 0.722 0.783 0.875
44 0.567 0.659 0.720 0.781 0.873
S81salud pública de méxico / vol. 51, suplemento 1 de 2009
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-2.5 -1.0 0.0 1.0 2.5 -2.5 -1.0 0.0 1.0 2.5
7 0.476 0.636 0.742 0.849 1.009 45 0.853 1.013 1.120 1.226 1.387
8 0.523 0.683 0.790 0.897 1.057 46 0.849 1.009 1.116 1.223 1.383
9 0.568 0.728 0.835 0.942 1.102 47 0.845 1.005 1.112 1.219 1.379
10 0.610 0.770 0.877 0.983 1.144 48 0.841 1.001 1.108 1.214 1.374
11 0.649 0.809 0.916 1.022 1.182 49 0.836 0.996 1.103 1.210 1.370
12 0.685 0.845 0.952 1.058 1.218 50 0.832 0.992 1.099 1.205 1.365
13 0.718 0.878 0.985 1.091 1.251 51 0.827 0.987 1.094 1.201 1.361
14 0.748 0.908 1.015 1.121 1.281 52 0.822 0.982 1.089 1.195 1.356
15 0.775 0.935 1.042 1.148 1.309 53 0.817 0.977 1.083 1.190 1.350
16 0.799 0.959 1.066 1.173 1.333 54 0.811 0.971 1.078 1.185 1.345
17 0.820 0.980 1.087 1.194 1.354 55 0.805 0.965 1.072 1.179 1.339
18 0.839 0.999 1.105 1.212 1.372 56 0.799 0.960 1.066 1.173 1.333
19 0.854 1.014 1.121 1.227 1.388 57 0.793 0.953 1.060 1.167 1.327
20 0.866 1.026 1.133 1.240 1.400 58 0.787 0.947 1.054 1.160 1.320
21 0.876 1.036 1.143 1.250 1.410 59 0.780 0.940 1.047 1.154 1.314
22 0.883 1.044 1.150 1.257 1.417 60 0.773 0.933 1.040 1.147 1.307
23 0.889 1.049 1.156 1.262 1.422 61 0.766 0.926 1.033 1.140 1.300
24 0.892 1.052 1.159 1.266 1.426 62 0.758 0.919 1.025 1.132 1.292
25 0.894 1.054 1.161 1.268 1.428 63 0.751 0.911 1.018 1.124 1.284
26 0.895 1.055 1.162 1.268 1.429 64 0.743 0.903 1.010 1.116 1.276
27 0.895 1.055 1.161 1.268 1.428 65 0.734 0.895 1.001 1.108 1.268
28 0.894 1.054 1.161 1.267 1.427 66 0.726 0.886 0.993 1.100 1.260
29 0.892 1.052 1.159 1.266 1.426 67 0.717 0.878 0.984 1.091 1.251
30 0.891 1.051 1.158 1.265 1.425 68 0.709 0.869 0.976 1.082 1.243
31 0.889 1.049 1.156 1.263 1.423 69 0.700 0.861 0.967 1.074 1.234
32 0.888 1.048 1.155 1.261 1.421 70 0.692 0.852 0.959 1.066 1.226
33 0.886 1.046 1.153 1.259 1.420 71 0.684 0.844 0.951 1.058 1.218
34 0.884 1.044 1.151 1.257 1.418 72 0.677 0.837 0.944 1.050 1.210
35 0.882 1.042 1.149 1.255 1.416 73 0.670 0.830 0.937 1.043 1.203
36 0.880 1.040 1.146 1.253 1.413 74 0.663 0.823 0.930 1.037 1.197
37 0.877 1.037 1.144 1.251 1.411 75 0.658 0.818 0.924 1.031 1.191
38 0.875 1.035 1.142 1.248 1.409 76 0.653 0.813 0.919 1.026 1.186
39 0.872 1.032 1.139 1.246 1.406 77 0.649 0.809 0.915 1.022 1.182
40 0.869 1.029 1.136 1.243 1.403 78 0.645 0.806 0.912 1.019 1.179
41 0.866 1.027 1.133 1.240 1.400 79 0.643 0.803 0.910 1.017 1.177
42 0.863 1.023 1.130 1.237 1.397 80 0.641 0.801 0.908 1.015 1.175
43 0.860 1.020 1.127 1.234 1.394
44 0.857 1.017 1.123 1.230 1.390
Artículo originAl
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Table A.2
statistical analysis for l2-l4
Percentage
Percentage of differences Exact probability Significance of differences
Deleze Cons et al Mexican
Normal 48.9% 47.5% 1.2981 0.0971 Not  significant
Osteopenia 37.8% 37.6% 0.1338 0.4468 Not  significant
Osteoporosis 13.3% 14.9% -2.0510 0.0201 Significant
Table A.3
coMParison of classification of feMoral neck density  Between the deleZe,
cons et al. classification using the Manufacturer’s reference values and our Mexican dataBase
using t-scores calculated for ages 20-39, 30-40 or PBM
 Groups according to Mexican data base Total
  Normal Osteopenia Osteoporosis Normal
Groups according to Deleze Cons et.al. Normal Count 1 600   651     0 2 251
  % of total     36.8%     15.0%       .0%     51.8%
 Osteopenia Count       0 1 428 326 1 754
  % of total         .0%     32.8%     7.5%     40.3%
 Osteoporosis Count       0       0 343   343
  % of total         .0%         .0%     7.9%       7.9%
Total Count 1 600 2 079 669 4 348
 % of total     36.8%     47.8%   15.4%  100.0%
Table A.4
statistical analysis for feMoral neck
Group
Percentage Percentage of differences Exact probability Significance of differences
Deleze Cons et al Mexican
Normal 51.8 36.8 14.1218 0.0000 Significant
Osteopenia 40.3 47.8  -7.0043 0.0000 Significant
Osteoporosis   7.9 15.4 -10.8836 0.0000 Significant
Table A.1
coMParison for l2-l4 Between the deleZe, cons et al. classification using the Manufacturer’s reference values 
and our Mexican dataBase using t-scores calculated with data for ages 20-39, 30-40 or PBM
 Groups according to Mexican data base Total
  Normal Osteopenia Osteoporosis
Groups according to Deleze, Cons et al. Normal Count 1 930   163     0 2 093
  % of total      45.1%       3.8%     0.0%      48.9%
 Osteopenia Count    103 1 361 152  1 616
  % of total        2.4%     31.8%     3.6%      37.8%
 Osteoporosis Count        0    86 484    570
  % of total        0.0%      2.0%   11.3%      13.3%
Total Count  2 033 1 610 636 4 279
 % of total      47.5%     37.6%   14.9%   100.0%
Appendix
